ONECELL DIAGNOSTICS, INC. – Trademark Portfolio
Entity Type: 03
ONECELL DIAGNOSTICS, INC. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ALIBREX. The owner is based in CUPERTINO, CA.
20380 TOWN CENTER LANE
SUITE 218
CUPERTINO, CA 95014
Showing of trademarks Trademarks
Trademark Classifications
ONECELL DIAGNOSTICS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ONECELL DIAGNOSTICS, INC. have?
ONECELL DIAGNOSTICS, INC. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does ONECELL DIAGNOSTICS, INC. file in?
ONECELL DIAGNOSTICS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are ONECELL DIAGNOSTICS, INC.'s most well-known trademarks?
ONECELL DIAGNOSTICS, INC.'s registered trademark portfolio includes well-known marks such as ALIBREX. These are among 1 currently registered trademark in the portfolio.
What is ONECELL DIAGNOSTICS, INC.'s trademark registration success rate?
ONECELL DIAGNOSTICS, INC. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.